219 related articles for article (PubMed ID: 28967995)
1. CASAAV: A CRISPR-Based Platform for Rapid Dissection of Gene Function In Vivo.
VanDusen NJ; Guo Y; Gu W; Pu WT
Curr Protoc Mol Biol; 2017 Oct; 120():31.11.1-31.11.14. PubMed ID: 28967995
[TBL] [Abstract][Full Text] [Related]
2. Engineering the Delivery System for CRISPR-Based Genome Editing.
Glass Z; Lee M; Li Y; Xu Q
Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo.
Guo Y; VanDusen NJ; Zhang L; Gu W; Sethi I; Guatimosim S; Ma Q; Jardin BD; Ai Y; Zhang D; Chen B; Guo A; Yuan GC; Song LS; Pu WT
Circ Res; 2017 Jun; 120(12):1874-1888. PubMed ID: 28356340
[TBL] [Abstract][Full Text] [Related]
4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
5. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
6. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
Yu W; Wu Z
Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
[TBL] [Abstract][Full Text] [Related]
7. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
8. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
[TBL] [Abstract][Full Text] [Related]
9. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
10. Somatic Gene Editing of
McCullough KT; Boye SL; Fajardo D; Calabro K; Peterson JJ; Strang CE; Chakraborty D; Gloskowski S; Haskett S; Samuelsson S; Jiang H; Witherspoon CD; Gamlin PD; Maeder ML; Boye SE
Hum Gene Ther; 2019 May; 30(5):571-589. PubMed ID: 30358434
[TBL] [Abstract][Full Text] [Related]
11. A multifunctional AAV-CRISPR-Cas9 and its host response.
Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
[TBL] [Abstract][Full Text] [Related]
12. An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting.
Cao J; Wu L; Zhang SM; Lu M; Cheung WK; Cai W; Gale M; Xu Q; Yan Q
Nucleic Acids Res; 2016 Nov; 44(19):e149. PubMed ID: 27458201
[TBL] [Abstract][Full Text] [Related]
13. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
Zhang Y; Li H; Min YL; Sanchez-Ortiz E; Huang J; Mireault AA; Shelton JM; Kim J; Mammen PPA; Bassel-Duby R; Olson EN
Sci Adv; 2020 Feb; 6(8):eaay6812. PubMed ID: 32128412
[TBL] [Abstract][Full Text] [Related]
14. Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats.
Bäck S; Necarsulmer J; Whitaker LR; Coke LM; Koivula P; Heathward EJ; Fortuno LV; Zhang Y; Yeh CG; Baldwin HA; Spencer MD; Mejias-Aponte CA; Pickel J; Hoffman AF; Spivak CE; Lupica CR; Underhill SM; Amara SG; Domanskyi A; Anttila JE; Airavaara M; Hope BT; Hamra FK; Richie CT; Harvey BK
Neuron; 2019 Apr; 102(1):105-119.e8. PubMed ID: 30792150
[TBL] [Abstract][Full Text] [Related]
15. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy.
Pickar-Oliver A; Gough V; Bohning JD; Liu S; Robinson-Hamm JN; Daniels H; Majoros WH; Devlin G; Asokan A; Gersbach CA
Mol Ther; 2021 Nov; 29(11):3243-3257. PubMed ID: 34509668
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of Cardiomyocyte Hypertrophy via Depletion Myh7 using CASAAV.
Yue P; Xia S; Wu G; Liu L; Zhou K; Liao H; Li J; Zheng X; Guo Y; Hua Y; Zhang D; Li Y
Cardiovasc Toxicol; 2021 Mar; 21(3):255-264. PubMed ID: 33098074
[TBL] [Abstract][Full Text] [Related]
17. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
[TBL] [Abstract][Full Text] [Related]
19. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
Pritchard CEJ; Kroese LJ; Huijbers IJ
Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
[TBL] [Abstract][Full Text] [Related]
20. Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses.
Yoon Y; Wang D; Tai PWL; Riley J; Gao G; Rivera-Pérez JA
Nat Commun; 2018 Jan; 9(1):412. PubMed ID: 29379011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
